1Alexandroff A B, JacKson A M, O' Donnell M A, et al. BCG immunotherapy of bladder cancer: 20 years on. Lancet, 1999, 353:1689 被引量：1
2Tsuji S, Matsumoto M, Takeuchi O, et al. Maturation of human dendritic cells by cellwall skeleton of Mycobactefium bovis bacillus Calmette-Guerin;involvement of toil- like receptors. Infect Immun, 2000, 68 (12) :6883 被引量：1
3de Boer E C, Somogyi L, de Ruiter G J, et al. Role of interleukin - 8 in onset of the immune response in intravesieal BCG therapy for superficial bladder cancer. Urol Res, 1997, 25(1): 31 被引量：1
4Thalmann G N, Sennier A, Rentsch C, et al. Urinary Interleukin- 8 and 18 predict the response of superficial bladder cancer to intravesical therapy with Bacillus Calmette - C, uerin. J Urol, 2000, 164(6) : 2129 被引量：1
5Jackson A M, Alexandroff A B, Kelly R W,et al. Changes in urinary cytokines and soluble intercellular adhesion nlolecule- 1 (ICAM - 1 ) in bidder cancer patients after Bacillus Calmette- Guerin (BCG) immunotherapy. Clin EXp hnmunul, 1995, 99(3) : 36 被引量：1
6Hirohashi S, Clansen H, Yamada T, et al. Blood group A cross- reacting epitope defined by monoclonal antibodies NCC - LU - 35 and - 81 expressed in cancer of blood group O or B individuals: its identification as Tnantigen. Proc Natl Acad Sci USA, 1985, 82(20) : 7039 被引量：1
7Nilsson K, Evrin P E, Welsh K I. Production of 132 - microglobulin bynormal and malignant human cell lines and peripheral lymphocytes. Transplant Rev, 1974, 21 (0) : 53 被引量：1
8Turbitt M l, Mackie R M. Loss of β2 microglobulin'from the cell surface of cutaneous malignant and premalignant lesions. Br J Dermatol, 1981, 104(5) : 507 被引量：1
9Hart 1 R, Birch M, Marshall J F. Cell adhesion receptor expression during melanoma progression and metastasis. Cancer Metastasis Rev, 1991, 10(2): 115 被引量：1
10Carballido J, Alvarez - Mon M, Solovera O J, et al. Clinical significance of natural killer activity in patients with transitional cell carcinoma of the bladder. J Urol, 1990, 143(1): 29 被引量：1
